Search clinical trials for: BIRC5 protein, human

Total 17134 results

Karolinska Institutet

Completed

The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma

Asthma | Allergy | Rhinitis
Lars Olaf Cardell

Completed

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass

Allergic Rhinitis

Sweden
Julius-Maximilians University

Unknown

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Cervical Cancer | Pancreatic Cancer | Colon Cancer | Malignant Melanoma

Germany
University of Pennsylvania

Completed

Multipeptide Vaccine for Advanced Breast Cancer

Breast Cancer | Breast Neoplasm | Carcinoma, Ductal | Cancer of the Breast

United States
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital; Sodra Alvsborgs Hospital

Completed

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

Rhinitis, Allergic

Sweden
University Hospital Erlangen

Completed

Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma

Melanoma (Skin)

Germany
South Valley University

Completed

Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases

Bronchial Neoplasm Benign
Ain Shams University

Unknown

Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

Preeclampsia
University of Alabama at Birmingham
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk

Microbial Colonization | Growth Failure | Breast Milk Expression | Feeding Disorder Neonatal | Prematurity; Extreme

United States
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital

Completed

Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy

Allergic Rhinitis

Sweden
Queen's University
University of British Columbia

Completed

Clinical Validation of Birch Pollen in the EEU

Allergic Rhinitis

Canada
Fraunhofer-Institute of Toxicology and Experimental...

Completed

Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)

Seasonal Allergic Rhinitis
Circassia Limited
Quintiles, Inc.; Adiga Life Sciences, Inc.

Completed

Birch-SPIRE Safety and Efficacy Study

Rhinitis

Canada
HAL Allergy

Completed

SUBLIVAC FIX Birch Phase III Short-term Efficacy

Birch Pollen Induced Rhinitis/Rhinoconjunctivitis

Belgium, Germany, Czech Republic, Poland, Slovakia
Leti Pharma GmbH

Completed

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma | Sensitization Against Betula Alba (Birch) Pollen

Germany
HAL Allergy

Completed

SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland, Czech Republic, Germany
Helsinki University Central Hospital
University of Helsinki; Finnish Institute of Occupational Health

Completed

The Effects of Immunotherapy in the Nose (Birch11)

Rhinitis, Allergic, Seasonal
Royal Sussex County Hospital

Terminated

Mechanisms of Allergen Immunotherapy

Allergic Rhinitis

United Kingdom
Stallergenes Greer
Quintiles, Inc.; Cenduit LLC; Aptuit Inc.; PHT Corporation

Completed

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Hypersensitivity | Allergic Rhinitis | Allergic Conjunctivitis | Seasonal Allergy

Czech Republic, Denmark, Estonia, Finland, France, Germany, Latvia, Lithuania, Poland, Slovakia, Sweden
KK Women's and Children's Hospital

Not yet recruiting

Targeted Fortification of Pasteurized Donor Human Milk

Growth Failure | Very Low Birth Weight Infant | Donor Breast Milk

Singapore
Sichuan Clover Biopharmaceuticals, Inc.

Terminated

A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

China
Clover Biopharmaceuticals AUS Pty Ltd

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions

Malignant Pleural Effusions

Australia
The Hospital for Sick Children

Completed

Bovine vs. Human Milk-Based Fortifier Study

Very Low Birth Weight Infant (<1250g)

Canada
St. Louis University

Completed

Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein

Premature Birth of Newborn | Human Milk

United States
Sichuan Clover Biopharmaceuticals, Inc.

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites

Malignant Ascites

China
Clover Biopharmaceuticals AUS Pty Ltd

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies

Peritoneal Malignancies

Australia
AB2 Bio Ltd.

Completed

Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease

Still's Disease, Adult-Onset

Germany, France, Switzerland
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Terminated

Exploratory Study of IMM01 for Injection in the Treatment of Refractory or Recurrent Hematologic Malignancy

Hematologic Malignancy

China
Royal Sussex County Hospital

Unknown

Can we Help People With the Oral Allergy Syndrome Eat Fresh Fruit?

Oral Allergy Syndrome

United Kingdom
ALK-Abelló A/S

Completed

Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch

Allergy

Germany
HAL Allergy
Ergomed

Completed

PURETHAL Birch RUSH Study

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland
Columbia University

Recruiting

Targeted Fortification of Donor Breast Milk in Preterm Infants

Growth Failure | Growth Retardation | Prematurity; Extreme | Infant Nutrition Disorders | Failure to Thrive in Newborn

United States
Stallergenes Greer

Terminated

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Allergy

France
Alyatec

Completed

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

Allergic Conjunctivitis

France
Sohag University

Recruiting

ATG5 as a Serum Marker of Autophagy in Psoriatic Patient

Psoriasis Vulgaris | Autophagy

Egypt
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States
Shire

Completed

A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE

Hereditary Angioedema

United States
Hengenix Biotech Inc

Completed

Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects

COVID 19

United States
Chengdu Kanghong Biotech Co., Ltd.
University of Wisconsin, Madison

Completed

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD (PHOENIX)

Neovascular Age-related Macular Degeneration

China
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital

Completed

Intralymphatic Immunotherapy in Increasing Doses, Substudy

Rhinitis, Allergic, Seasonal

Sweden
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever

Allergy

Germany
Shire
Halozyme Therapeutics

Completed

A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase

Hereditary Angioedema

United States
Shire

Completed

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Hereditary Angioedema (HAE)

United States, Germany, Spain, Sweden
Allergopharma GmbH & Co. KG

Completed

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Birch Pollen Allergy

Germany
University Hospital, Gentofte, Copenhagen

Recruiting

LEAP2 on Postprandial Glucose Metabolism and Food Intake n Obese Males (LEAP2-OBCT)

Obesity

Denmark
Rigshospitalet, Denmark

Recruiting

Diagnosing Ovarian Cysts - the DOC Study

Ovarian Cysts | Ovarian Neoplasms | Ovarian Cancer | Ovarian Cancer Stage

Denmark
Hamad Medical Corporation

Recruiting

Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resection Surgeries

Coagulation; Intravascular | Fluid Electrolyte Disorders

Qatar
Fraunhofer-Institute of Toxicology and Experimental...

Recruiting

Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis (UBAMBI)

Allergic Rhinitis | Seasonal Allergic Rhinitis | Birch Pollen Allergy | Ragweed Allergy

Germany
Azienda Ospedaliera Universitaria Integrata Verona

Not yet recruiting

A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction (BoRgES)

Esophageal Cancer
Purdue University

Completed

Impact of Protein Quantity Within the USDA Healthy Style Eating Pattern on Sleep

Sleep | Body Composition

United States

Search clinical trials for: BIRC5 protein, human

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations